Revance Therapeutics, Inc. (RVNC)

Revance Therapeutics Statistics

Total Valuation

RVNC has a market cap or net worth of $554.52 million. The enterprise value is $813.91 million.

Market Cap	554.52M
Enterprise Value	813.91M

Important Dates

The next estimated earnings date is Wednesday, November 6, 2024, after market close.

Earnings Date	Nov 6, 2024
Ex-Dividend Date	n/a

Share Statistics

RVNC has 104.82 million shares outstanding. The number of shares has increased by 16.41% in one year.

Shares Outstanding	104.82M
Shares Change (YoY)	+16.41%
Shares Change (QoQ)	+13.00%
Owned by Insiders (%)	1.72%
Owned by Institutions (%)	61.68%
Float	85.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.94
Forward PS	1.63
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	3.24
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.74

Current Ratio	3.74
Quick Ratio	2.87
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-9.29

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-22.77%
Return on Capital (ROIC)	-30.30%
Revenue Per Employee	$420,734
Profits Per Employee	-$481,575
Employee Count	597
Asset Turnover	0.46
Inventory Turnover	3.01

Taxes

In the past 12 months, RVNC has paid $300,000 in taxes.

Income Tax	300,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.47% in the last 52 weeks. The beta is 0.98, so RVNC's price volatility has been similar to the market average.

Beta (5Y)	0.98
52-Week Price Change	-37.47%
50-Day Moving Average	5.94
200-Day Moving Average	4.72
Relative Strength Index (RSI)	44.49
Average Volume (20 Days)	1,335,317

Short Selling Information

The latest short interest is 9.54 million, so 9.10% of the outstanding shares have been sold short.

Short Interest	9.54M
Short Previous Month	7.63M
Short % of Shares Out	9.10%
Short % of Float	11.17%
Short Ratio (days to cover)	1.89

Income Statement

In the last 12 months, RVNC had revenue of $251.18 million and -$287.50 million in losses. Loss per share was -$3.11.

Revenue	251.18M
Gross Profit	96.56M
Operating Income	-199.01M
Pretax Income	-287.20M
Net Income	-287.50M
EBITDA	-192.06M
EBIT	-199.01M
Loss Per Share	-$3.11

Balance Sheet

The company has $232.24 million in cash and $491.64 million in debt, giving a net cash position of -$259.39 million or -$2.47 per share.

Cash & Cash Equivalents	232.24M
Total Debt	491.64M
Net Cash	-259.39M
Net Cash Per Share	-$2.47
Equity (Book Value)	-129.74M
Book Value Per Share	-1.24
Working Capital	256.54M

Cash Flow

In the last 12 months, operating cash flow was -$200.76 million and capital expenditures -$8.46 million, giving a free cash flow of -$209.22 million.

Operating Cash Flow	-200.76M
Capital Expenditures	-8.46M
Free Cash Flow	-209.22M
FCF Per Share	-$2.00

Margins

Gross margin is 38.44%, with operating and profit margins of -79.23% and -114.46%.

Gross Margin	38.44%
Operating Margin	-79.23%
Pretax Margin	-121.05%
Profit Margin	-114.46%
EBITDA Margin	-76.46%
EBIT Margin	-79.23%
FCF Margin	-85.78%

Dividends & Yields

RVNC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.41%
Shareholder Yield	-16.41%
Earnings Yield	-51.85%
FCF Yield	-37.73%

Analyst Forecast

The average price target for RVNC is $10.86, which is 105.29% higher than the current price. The consensus rating is "Buy".

Price Target	$10.86
Price Target Difference	105.29%
Analyst Consensus	Buy
Analyst Count	10
Revenue Growth Forecast (5Y)	25.85%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

RVNC has an Altman Z-Score of -5.55 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.55
Piotroski F-Score	2